ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $144,160,208.13
- March 13, 2026
- Muthusamy Shanmugam
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 13, 2026 | Insider | 3,162 | $71.64 | Sell | $226,525.68 | |
| March 13, 2026 | VP | 500 | $72.62 | Sell | $36,310.00 | |
| March 11, 2026 | SVP | 4,772 | $74.91 | Sell | $357,470.52 | |
| March 5, 2026 | CFO | 7,312 | $75.50 | Sell | $552,056.00 | |
| March 3, 2026 | SVP | 2,060 | $76.50 | Sell | $157,590.00 | |
| March 2, 2026 | Insider | 417 | $74.00 | Sell | $30,858.00 | |
| Feb. 20, 2026 | SVP | 1,730 | $77.99 | Sell | $134,922.70 | |
| Feb. 20, 2026 | Insider | 5,323 | $78.02 | Sell | $415,300.46 | |
| Sept. 19, 2025 | SVP | 1,000 | $98.04 | Sell | $98,040.00 | |
| Sept. 12, 2025 | VP | 400 | $98.42 | Sell | $39,368.00 | |
| Sept. 3, 2025 | Director | 7,292 | $94.94 | Sell | $692,302.48 | |
| Aug. 25, 2025 | Director | 2,528 | $90.62 | Sell | $229,087.36 | |
| Aug. 22, 2025 | SVP | 1,763 | $91.10 | Sell | $160,609.30 | |
| Aug. 21, 2025 | COO | 52,988 | $90.44 | Sell | $4,792,234.72 | |
| Aug. 20, 2025 | COO | 47,012 | $90.27 | Sell | $4,243,773.24 | |
| Aug. 20, 2025 | Director | 5,421 | $89.73 | Sell | $486,426.33 | |
| Aug. 18, 2025 | Director | 21,540 | $89.15 | Sell | $1,920,291.00 | |
| Aug. 18, 2025 | Director | 6,937 | $88.17 | Sell | $611,635.29 | |
| Aug. 15, 2025 | SVP | 20,000 | $86.97 | Sell | $1,739,400.00 | |
| Aug. 15, 2025 | COO | 52,990 | $87.15 | Sell | $4,618,078.50 | |
| Aug. 15, 2025 | Director | 9,000 | $89.05 | Sell | $801,450.00 | |
| Aug. 14, 2025 | COO | 47,010 | $89.48 | Sell | $4,206,454.80 | |
| Aug. 13, 2025 | VP | 400 | $88.87 | Sell | $35,548.00 | |
| Aug. 12, 2025 | Director | 19,341 | $85.93 | Sell | $1,661,972.13 | |
| Aug. 12, 2025 | SVP | 4,975 | $85.71 | Sell | $426,407.25 | |
| Aug. 12, 2025 | CEO | 56,960 | $85.93 | Sell | $4,894,572.80 | |
| Aug. 12, 2025 | SVP | 5,873 | $86.53 | Sell | $508,190.69 | |
| Aug. 12, 2025 | CFO | 50,000 | $86.07 | Sell | $4,303,500.00 | |
| July 14, 2025 | VP | 400 | $64.88 | Sell | $25,952.00 | |
| June 13, 2025 | VP | 400 | $61.37 | Sell | $24,548.00 | |
| May 15, 2025 | SVP | 881 | $60.07 | Sell | $52,921.67 | |
| May 14, 2025 | Insider | 4,000 | $60.45 | Sell | $241,800.00 | |
| April 14, 2025 | VP | 400 | $68.96 | Sell | $27,584.00 | |
| March 13, 2025 | VP | 400 | $63.33 | Sell | $25,332.00 | |
| March 7, 2025 | SVP | 1,000 | $60.86 | Sell | $60,860.00 | |
| Feb. 21, 2025 | SVP | 1,000 | $60.20 | Sell | $60,200.00 | |
| Feb. 13, 2025 | VP | 400 | $59.54 | Sell | $23,816.00 | |
| Jan. 13, 2025 | VP | 400 | $53.92 | Sell | $21,568.00 | |
| Dec. 17, 2024 | CFO | 7,500 | $55.79 | Sell | $418,425.00 | |
| Dec. 11, 2024 | SVP | 1,000 | $60.00 | Sell | $60,000.00 | |
| Nov. 26, 2024 | CEO | 33,481 | $57.99 | Sell | $1,941,563.19 | |
| Oct. 14, 2024 | VP | 250 | $57.19 | Sell | $14,297.50 | |
| Sept. 13, 2024 | VP | 250 | $56.82 | Sell | $14,205.00 | |
| Aug. 13, 2024 | VP | 250 | $59.62 | Sell | $14,905.00 | |
| July 17, 2024 | COO | 14,257 | $63.16 | Sell | $900,472.12 | |
| July 15, 2024 | COO | 11,000 | $63.38 | Sell | $697,180.00 | |
| July 12, 2024 | VP | 250 | $64.91 | Sell | $16,227.50 | |
| July 1, 2024 | SVP | 20,000 | $63.44 | Sell | $1,268,800.00 | |
| June 21, 2024 | COO | 20,000 | $58.90 | Sell | $1,178,000.00 | |
| June 13, 2024 | VP | 250 | $63.80 | Sell | $15,950.00 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Nikhil Lalwani, Krista Davis, Arthur Przybyl, Stephen P Carey, Christopher Mutz, Ori Gutwerg, Patrick D Walsh, Robert W Schrepfer, Thomas Haughey, Antonio R Pera, Ross J Mangano, Thomas Andrew Rowland, Matthew J Leonard, Daniel Raynor, Jeanne Thoma, David Nash, Ross Mangano, and Renee P Tannenbaum
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 36 trades.
Muthusamy Shanmugam has sold the most ANI Pharmaceuticals Inc stock with a total value of $45,394,142.03.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.
